Abstract
The prevalence of hypogonadism has been found to be increased in certain chronic illnesses, especially diabetes, hypertension and obesity. Recently, the prevalence of hypogonadism in primary care practices mirrored that in our population of men with erectile dysfunction (ED). In this study, the prevalence of hypogonadism in nearly 1000 men with ED was tabulated, using a retrospective chart review, and analyzed for association with the various contributing medical and psychological factors. The prevalence of hypogonadism was determined in men with a variety of chronic illnesses, and was further characterized by decade. We observed an association between hypertension (P=0.025), tobacco abuse (P=0.0059), sleep apnea (P=0.0001), work stress (P=0.041) and hypogonadism. These data were further analyzed for the odds ratio and confidence interval (Forest plot), which showed strong association for sleep apnea and work stress. We did not observe any significant association between diabetes, atherosclerosis, alcohol abuse, multiple medications, asthma, seizure disorder, anxiety/depression and hypogonadism (P values for Cochran–Mantel–Haenszel general association were 0.48, 0.97, 0.25, 0.69, 0.22, 0.76 and 0.98, respectively). We suggest that a host of chronic illnesses have a high prevalence of secondary hypogonadism. Men who have chronic medical or psychological illnesses should have their testosterone level checked, especially when sexual dysfunction symptoms or signs are present.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kaufman JM, Vermeulen A . the decline of androgen levels in elderly men and its clinical and therapeutic implications. End Rev 2005; 26: 833–876.
Seftel AD . Male hypogonadism. Part I: Epidemiology of hypogonadism. Int J Impot Res 2006; 18: 115–120.
Gray A, Feldman HA, McKinlay JB, Longcope C . Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73: 1016–1025.
Wespes E, Schulman CC . Male andropause: myth, reality, and treatment. Int J Impot Res 2002; 14 (S1): S93–S98.
Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS et al. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006; 91: 1995–2010.
Morley JE, Kaiser FE, Perry 3rd HM, Patrick P, Morley PMK, Stauber PM et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997; 46: 410–413.
Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al. Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004; 89: 5920–5926.
Araujo AB, Gretchen R, Esche MS, Kupelian V, O'Donnell AB, travison TG et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007; 92: 4241–4247.
Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C . Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006; 60: 762–769.
Makhlouf AA, Mohamed MA, Seftel AD, Neiderberger C . Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction. Int J Impot Res 2008; 20: 157–161.
Dobs A . testosterone deficiency and supplementation in chronic disease states. Med Clin North Am 2006; 90 (S1): 14–18.
Ding EL, Song Y, Malik VS, Liu S . Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. J Am Med Assoc 2006; 295: 1288–1299.
Chandel A, Dhinsa S, Topiwala S, Chadhuri A, Dandona P . Testosterone concentration in young patients with diabetes. Diabetes Care 2008; 31: 2013–2017.
Seftel A . Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. Int J Impot Res 2006; 18: 223–228.
Buvat J, Shabsigh R, Guay A, Gooren L, Torres LO, Meulemen E . Chapter 18: Hormones, metabolism, aging, and men's health. In: Porst H, Buvat J (eds). Standard Practice in Sexual Medicine. Blackwell Publishing: Oxford, UK, 2006, pp, 225–286.
Handelsman DJ, Zajac JD . Androgen deficiency and replacement therapy in men. Med J Aust 2004; 180: 529–535.
Van der Berghe G, de Zegher F, Bouillon R . Acute and chronic illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 83: 1827–1834.
Karagiannis A, Harsoulis F . Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005; 152: 501–513.
Guay AT, Velasquez E, Perez JB . Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract 1999; 5: 314–321.
Walczak MK, Lokhandwala N, Hodge MB, Guay AT . Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19–24.
Guay AT, Jacobson J . The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction. J Sex Med 2007; 4: 1046–1055.
Seftel AD, Sun P, Swindle R . the prevalence of hypertension, hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction. J Urol 2004; 171: 2341–2345.
Bjornerem A, Straume S, Midtby M, Fonnebo V, Sundsfjord J, Svartberg J et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004; 89: 6039–6047.
Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T-P, Valkonen V-P et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004; 27: 1036–1041.
Muller M, Grobbee DF, den Tonkelaar I, Lamberts SW, van der Schouw YT . Endogenous sex hormones and the metabolic syndrome in aging men. J Clin Endocrinol Metab 2005; 90: 2618–2623.
Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al. Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 2006; 50: 595–604.
Jackson G . The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism. Eur Urol 2006; 50: 426–427.
Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005; 90: 2636–2641.
Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson E-K et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005; 28: 1636–1642.
Ponholzer A, Temml C, Obermayer R, Wehrberger C, Madersbacher S . Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 2005; 48: 512–518.
Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R . Erectile dysfunction is a marker for cardiovascular disease: results of the Minority Health Institute Expert Advisory Panel. J Sex Med 2005; 2: 40–52.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB . Impotence and its medical and psychosocial correlates; results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
Araujo AB, Durante R, Feldman HA, Goldstein I, McKinlay JB . The relationship between depressive symptoms and male erectile dysfunction; cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–465.
Shores MM, Sloan KL, Matsumoto AM, Moceri VM, Felker B, Kivlahan DR . in creased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry 2004; 61: 162–167.
Stanworth RD, Kapoor D, CHanner KS, Jones TH . Statin therapy is associated with lower total but not bioavailable of free testosterone in men with type 2 diabetes. Diabetes Care 2009; 32: 541–546.
Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M . Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985; 60: 444–450.
Vogel AV, Peake GT, Rada RT . Pituitary-testicular axis dysfunction in burned men. J Clin Endocrinol Metab 1985; 60: 658–665.
Van Thiel DH . Ethanol: its adverse effects upon the hypothalamic-pituitary-gonadal axis. J Lab Clin Med 1983; 101: 21–33.
Lam KSL, Wang C, Yeung RTT, Ma JTC, Ho JHC, Tse VKC et al. Hypothalamic hypopituitarism following cranial irradiation for nasopharyngeal carcinoma. Clin Endocrinol 1986; 24: 643–651.
Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M . Transient hypogonadotropic hypogonadism after head trauma: effects on steroid precursors and correlation with sympathetic nervous system activity. Clin Endocrinol 1986; 25: 265–274.
Kreuz LE, Rose RM, Jennings JR . Suppression of plasma testosterone levels and psychological stress: a longitudinal study of young men in officer candidate school. Arch Gen Psychiatry 1972; 26: 479–482.
Opstad PK . Androgenic hormones during prolonged physical stress, sleep, and energy deficiency. J Clin Endocrinol Metab 1992; 74: 1176–1183.
Rose RM, Bourne PG, Poe RO, Mougey EH, Collins DR, Mason JW . Androgen responses to stress. II Excretion of testosterone, epitestosterone, androsterone and etiocholanolone during basic combat training and under threat of attack. Psychosom Med 1969; 31: 418–436.
MacConnie SE, Barkan A, Lampsan RM, Schork MA, Beitins IZ . Decreased hypothalamic gonadotropin-releasing hormone secretion in male marathon runners. N Engl J Med 1986; 315: 411–417.
Strauss RH, Lanese RR, Malarkey WB . Weight loss in amateur wrestlers and its effect on serum testosterone levels. JAMA 1985; 254: 3337–3338.
Barron JL, Noakes TD, Levy W, Smith C, Millar RP . Hypothalamic dysfunction in overtrained athletes. J Clin Endocrinol Metab 1985; 60: 803–806.
Sato Y, Suzuki N, Horita H, Wada H, Shibuya A, Adachi H et al. Effects of long-term psychological stress on sexual behavior and brain catecholamine levels. J Androl 1996; 17: 83–90.
Demura R, Suzuki T, Nakamura S, Komatsu H, Odagiri E, Demura H . Effect of immobilization stress on testosterone and inhibin in male rats. J Androl 1989; 10: 210–213.
Orr TE, Taylor MF, Bhattacharyya AK, Collins DC, Mann DR . Acute immobilization stress disrupts testicular steroidogenesis in adult male rats by inhibiting the activities of 17α-hydroxylase and 17,20-lyasewithout affecting the binding of LH.hCG receptors. J Androl 1994; 15: 302–308.
Richter SD, Schurmeyer TH, Schedlowski M, Hadicke A, tewes U, Schmidt RE et al. Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab 1996; 81: 1956–1960.
Guay AT, Jacobson J, Perez JB, Hodge MB, Velasquez E . Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction; who does and does not respond? Int J Impot Res 2003; 15: 156–165.
Guay AT, Bansal S, Heatley GJ . Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80: 3546–3552.
Sun P, Cameron A, Seftel A, Shabsigh R, Niederberger C, Guay A . Erectile dysfunction—an observable marker of diabetes mellitus? A large national epidemiological study. J Urol 2006; 176: 1081–1085.
Corona G, Mannucci E, Fisher AD, Lotti F, Petrone L, Balercia G et al. Low levels of androgens in men with erectile dysfunction and obesity. J Sex Med 2008; 5: 2454–2463.
Bolona ER, Uraga MV, Haddad RM, Tracz MJ, Sideras K, Kennedy CC et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc 2007; 82: 20–28.
Hall SA, Esche GR, Araujo AB, Travison TG, Clark RV, Willaims RE et al. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. J Clin Endocrinol Metab 2008; 93: 3870–3877.
Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB . The relative contributions of aging, health, and lifestyle fafctors to serum testosterone decline in men. J Clin Endocrinol Metab 2007; 92: 549–555.
Wu FCW, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW et al. The European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 2008; 93: 2737–2745.
Acknowledgements
This work was solely supported by the Department of Endocrinology, Lahey Clinic, the Department of Urology, Case Western Reserve University and the Department of Urology, Boston University School of Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guay, A., Seftel, A. & Traish, A. Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses. Int J Impot Res 22, 9–19 (2010). https://doi.org/10.1038/ijir.2009.46
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2009.46
Keywords
This article is cited by
-
Penile constitutive nitric oxide synthase expression in rats exposed to unpredictable chronic mild stress: role of inflammation
International Journal of Impotence Research (2017)
-
The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease
Reviews in Endocrine and Metabolic Disorders (2015)
-
Late Onset Hypogonadism, Testosterone Replacement Therapy, and Sexual Health in Elderly Men
Current Translational Geriatrics and Experimental Gerontology Reports (2013)
-
Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer
Journal of Hematology & Oncology (2011)